Literature DB >> 17069097

Postoperative ST-segment elevation: was vasospasm caused by anaphylaxis or by its treatment with epinephrine?

Sara Goldhaber-Fiebert1, Loreta Grecu.   

Abstract

BACKGROUND: Anaphylaxis must be recognized and treated promptly to avoid significant morbidity and mortality. In this clinical setting, electrocardiographic changes can be multifactorial.
OBJECTIVE: To discuss vasospasm as a cause of myocardial ischemia and its possible triggering by anaphylaxis itself or by the administration of epinephrine.
METHODS: We describe a patient with multiple previous allergies who received intravenous epinephrine to treat suspected anaphylaxis. She immediately developed crushing chest pain with ST-segment elevations in the inferior leads. Throughout the discussion, we address differential diagnoses, physiologic features, and treatment.
RESULTS: Her symptoms and electrocardiographic changes were consistent with vasospasm, which resolved after treatment with sublingual nitroglycerin. However, the reaction was sufficient to cause an elevation in the troponin T level and, therefore, myocardial damage on the cellular level.
CONCLUSIONS: Cardiovascular complications, including electrocardiographic changes, may be induced by anaphylactic mediators or by medications used for its treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17069097     DOI: 10.1016/S1081-1206(10)60933-7

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  2 in total

1.  Epinephrine: the drug of choice for anaphylaxis-a statement of the world allergy organization.

Authors:  Stephen F Kemp; Richard F Lockey; F Estelle R Simons
Journal:  World Allergy Organ J       Date:  2008-07       Impact factor: 4.084

2.  Intramuscular Epinephrine-Induced Transient ST-Elevation Myocardial Infarction.

Authors:  Binav Shrestha; Paritosh Kafle; Shivani Thapa; Suyash Dahal; Vijay Gayam; Alix Dufresne
Journal:  J Investig Med High Impact Case Rep       Date:  2018-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.